Jim Simons acquired 327k Cullinan Therapeutics shares worth $4.08M. That's 0.01% of their equity portfolio (1472nd largest holding). The first Cullinan Therapeutics trade was made in Q2 2021. Since then Jim Simons bought shares twelve more times and sold shares on eight occasions. The stake costed the investor $3.66M, netting the investor a gain of 12% so far.